Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 45 out of 100. Down syndrome and Alzheimer's

Topic: Amyloid, tau and blood-test diagnosis

Plain-language summary

BackgroundMost adults with Down syndrome will develop Alzheimer's disease (AD) due to the triplication of the amyloid precursor protein in the 21 st chromosome. Predictors of condition onset are less known.ObjectiveWe used Medicaid and Medicare data and machine learning to identify which co-occurring conditions predict incident AD in United States adults with Down syndrome.MethodsWe examined adults with Down syndrome enrolled in Medicaid and/or Medicare between 2011 and 2019. We identified AD and other conditions using ICD 9 and 10 codes. We used a case-control design with risk set sampling to have that controls to mimic the distribution of times of incident AD. We trained gradient boosted trees to identify strongest predictors.ResultsThe cohort had a mean age at entry of 44.6 years, 46.2% were male, and 73.7% were white non-Hispanic. 16,398 had incident AD diagnoses over the study period. The machine learning model had an area under the curve of 0.86 and high positive predictive value. Strongest predictors of increased probability of AD were age, dual Medicaid/Medicare enrollment; incident epilepsy or incident ulcer three years before index date; any hypothyroidism, schizophrenia, or hyperlipidemia. We found synergistic interaction between epilepsy and enrollment by age.ConclusionsPredictors aligned with known predictors in the general population and characteristics that signal AD symptom onset. New onset epilepsy may be a relevant clinical sign. Identifying these predictors highlights areas for further etiologic inquiry and intervention.

What this study adds

Evidence grade: Moderate

This is a case-control study. Using Medicaid and Medicare data and machine learning, this case-control study identified age, dual enrollment, incident epilepsy or ulcer, hypothyroidism, schizophrenia and hyperlipidemia as predictors of Alzheimer's disease diagnosis in adults with Down syndrome. Reported effect size: 46.2%; 73.7%.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Rubenstein, E., Tewolde, S., Michals, A., Fortea, J., Jimenez, M. P., Skotko, B. G., et al. (2025). Novel predictors of Alzheimer's disease in Down syndrome identified using machine learning. Journal of Alzheimer's disease : JAD. https://doi.org/10.1177/13872877251385423

Vancouver

Rubenstein E, Tewolde S, Michals A, Fortea J, Jimenez MP, Skotko BG, et al. Novel predictors of Alzheimer's disease in Down syndrome identified using machine learning. Journal of Alzheimer's disease : JAD. 2025. doi:10.1177/13872877251385423. PMID: 41105592.

BibTeX

@article{rubenstein2025-41105592,
  author  = {Rubenstein, E. and Tewolde, S. and Michals, A. and Fortea, J. and Jimenez, M. P. and Skotko, B. G. and Tripodis, Y. and Weuve, J. and others},
  title   = {{Novel predictors of Alzheimer's disease in Down syndrome identified using machine learning}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2025},
  doi     = {10.1177/13872877251385423},
  pmid    = {41105592},
  url     = {https://doi.org/10.1177/13872877251385423}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Why it matters

Using Medicaid and Medicare data and machine learning, this case-control study identified age, dual enrollment, incident epilepsy or ulcer, hypothyroidism, schizophrenia and hyperlipidemia as predictors of Alzheimer's disease diagnosis in adults with Down syndrome. These are risk associations for prediction, not evidence of a treatment, cure or prevention.

Study details

How this study scored 45/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 6 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 2 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 2 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 2 of 3; Multicenter collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read 0 of 2. Total 45 of 100.45 of 100 points earned55 not earned

Published in a peer-reviewed journal, and it is a case-control study. Scored zero for sample size, studied in people and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Journal of Alzheimer's disease : JAD)
Journal's citation record 2 / 4 Journal of Alzheimer s Disease: journal h-index 218 (OpenAlex, 2026-10-29)
Study design 6 / 12 A case-control study
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 2 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.7 citations a year over 3 year(s) since 2025
Impact for its field and year 2 / 6 Cited 1.7× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Anthony J. Rosellini: h-index 32 (OpenAlex, whole career)
Institution's track record 2 / 3 Massachusetts General Hospital: institution h-index 2,057 (OpenAlex)
Multicenter collaboration 2 / 3 OpenAlex lists 5 institution(s) in 2 countries
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41105592)
Free to read 0 / 2 Behind a paywall — scores zero
Total 45 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Down syndrome and Alzheimer's from nearby years

Also tagged “down”

527 studies in the library carry the topic tag “down”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 527 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Down syndrome and Alzheimer's

See all studies in Down syndrome and Alzheimer's →